Trypanosoma cruzi: Use of herpes simplex virus-thymidine kinase as a negative selectable marker

Experimental Parasitology

Volumn 86, Issue 3, 1997, Pages 171-180

  Buckner, Frederick S ^a   Wilson, Aaron J ^a   Van Voorhis, Wesley C ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Chaga's disease; Ganciclovir (GCV); Herpes simplex virus thymidine kinase (HSV TK); Hygromycin; Negative selection; Trypanosoma cruzi

Indexed keywords

GANCICLOVIR; HYGROMYCIN; THYMIDINE KINASE;

ARTICLE; CHAGAS DISEASE; DISEASE CONTROL; DNA DETERMINATION; ENZYME ACTIVITY; EPIMASTIGOTE; GENE EXPRESSION; HERPES SIMPLEX VIRUS; MARKER GENE; PARASITEMIA; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TRYPANOSOMA CRUZI;

ANIMALIA; HERPES; INSECTA; MAMMALIA; PROTOZOA; SIMPLEXVIRUS; TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 0031194632     PISSN: 00144894     EISSN: None     Source Type: Journal    
DOI: 10.1006/expr.1997.4163     Document Type: Article

References (30)

1. Ajioka, J., and Swindle, J. 1992. The calmodulin-ubiquitin associated genes of Trypanosoma cruzi: Their identification and transcription. Molecular and Biochemical Parasitology 57, 127-136.
2. Berens, R. L., Marr, J. J., LaFon, S. W., and Nelson, D. J. 1981. Purine metabolism in Trypanosoma cruzi. Molecular and Biochemical Parasitology 3, 187-196.
3. Brinster, R. L., Chen, H. Y., Trumbauer, M., Senear, A. W., Warren, R., and Palmiter, R. D. 1981. Somatic expression of herpes thymidine kinase in mice following injection of a fusion gene into eggs. Cell 27, 223-231.
4. Buckner, F. S., Verlinde, C. L. M. J., La Flamme, A. C., and Van Voorhis, W. C. 1996. Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing β-galactosidase. Antimicrobial Agents and Chemotherapy 40, 2592-2597.
5. Buhles, W. C. 1991. Clinical safety of intravenous ganciclovir. In "Ganciclovir Therapy for Cytomegalovirus Infection" (S.A. Spector, Ed.), pp. 31-69. Dekker, New York.
6. Capparelli, E. V., Lane, J. R., Sonke, R. L., and Connor, J. D. 1991. Ganciclovir pharmacokinetics. In "Ganciclovir Therapy for Cytomegalovirus Infection" (S. A. Spector, Ed.), pp. 71-81. Dekker, New York.
7. + cells harboring a human immunodeficiency virus-inducible suicide gene prevents viral spread in an infected cell population. Proceedings of the National Academy of Sciences of the United States of America 89, 182-186.
8. Chung, S., Gillespie, R. D., and Swindle, J. 1994. Analyzing expression of the calmodulin and ubiquitin-fusion genes of Trypanosoma cruzi using simultaneous, independent dual gene replacements. Molecular and Biochemical Parasitology 63, 95-107.
9. Cooper, R., de-Jesus, A. R., and Cross, G. A. 1993. Deletion of an immunodominant Trypanosoma cruzi surface glycoprotein disrupts flagellum-cell adhesion. Journal of Cell Biology 122, 149-156.
10. Cunha-Neto, E., Coelho, V., Guilherme, L., Giorelli, A., Stolf, N., and Kalil, J. 1996. Autoimmunity in Chagas' disease. Identification of cardiac myosin-B13 Trypanosoma cruzi protein crossreactive T cell clones in heart lesions of a chronic Chagas' cardiomyopathy patient. Journal of Clinical Investigation 98, 1709, 1712.
11. Ezzeddine, Z. T., Martuza, R. I., Platika, D., Short, M. P., Malick, A., Choi, B., and Breakefield, X. O. 1991. Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase. New Biology 3, 608-614.
12. Finley, R. W., Cooney, D. A., and Dvorak, J. A. 1988. Nucleoside uptake in Trypanosoma cruzi: Analysis of a mutant resistant to tubercidin. Molecular and Biochemical Parasitology 31, 451-455.
13. Gronowitz, J. S., Kallander, C. F. R., Diderholm, H., Hagberg, H., and Pettersson, U. 1984. Application of an in vitro assay for serum thymidine kinase: Results on viral disease and malignancies in humans. International Journal of Cancer 33, 5-12.
14. Hammond, D. J., and Gutteridge, W. E. 1984. Purine and pyrimidine metabolism in the Trypansomatidae. Molecular and Biochemical Parasitology 13, 243-261.
15. Hariharan, S., Ajioka, J., and Swindle, J. 1993. Stable transformation of Trypanosoma cruzi: Inactivation of the PUB12.5 polyubiquitin gene by targeted gene disruption. Molecular and Biochemical Parasitology 57, 15-30.
16. Kalil, J., and Cunha-Neto, E. 1996. Autoimmunity in Chagas disease cardiomyopathy: Fulfilling the criteria at last? Parasitology Today 12, 396-399.
17. La Flamme, A. C., Buckner, F. S., Swindle, J., Ajioka, J., and Van Voorhis, W. C. 1996. Trypanosoma cruzi: Expression of interleukin-2 utilizing both supercoiled plasmids and linear DNAs. Experimental Parasitology 83, 159-163.
18. Lebowitz, J. H., Cruz, A., and Beverley, S. M. 1992. Thymidine kinase as a negative selectable marker in Leishmania major. Molecular and Biochemical Parasitology 51, 321-326.
19. Lupton, S. D., Bruton, L. L., Kalberg, V. A., and Overell, R. W. 1991. Dominant positive and negative selection using a hygromycin phosphotransferase-thymidine kinase fusion gene. Molecular and Cellular Biology 11, 3374-3378.
20. Lye, L., and Wang, C. C. 1996. Thymidine kinase as a selectable marker for studying the biogenesis of glycosomes in Trypanosoma brucei. Experimental Parasitology 82, 211-217.
21. Mansour, S. L., Thomase, K. R., and Capecchi, M. R. 1988. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: A general strategy for targeting mutations to non-selectable genes. Nature 336, 348-352.
22. Moolten, F. L., and Wells, J. M. 1990. Curability of tumors bearing herpes simplex virus thymidine kinase gene. The Journal of the National Cancer Institute 82, 297-300.
23. Otsu, K., Donelson, J. E., and Kirchhoff, L. V. 1995. Trypanosoma cruzi: Interruption of both alleles of a gene encoding a protein containing 14-amino-acid repeats by targeted insertion of NEOr and HYGr. Experimental Parasitology 81, 529-535.
24. Palmiter, R. D., Behringer, R. R., Quaife, C. J., Maxwell, I. H., and Brinster, R. L. 1987. Cell lineage ablation in transgenic mice by cell-specific expression of a toxin gene. Cell 50, 435-443.
25. Plautz, G., Nabel, E. G., and Nabel, G. J. 1991. Selective elimination of recombinant genes in vivo with a suicide retroviral vector. New Biology 3, 709-715.
26. Plunkett, W., and Cohen, S. S. 1977. Penetration of mouse fibroblasts by 2′-deoxyadenosine 5′-phosphate and incorporation of the nucleotide into DNA. Journal of Cell Physiology 91, 261-270.
27. Ram, Z., Culver, K. W., Walbridge, R., Blaese, R. M., and Oldfiled, E. H. 1993. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Research 53, 83-88.
28. Takamiya, Y., Short, M. P., Ezzidine, Z. T., Moolten, F. L., Breakefield, X. O., and Martuza, R. L. 1992. Gene therapy on malignant brain tumors. A rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells. Journal of Neuroscience Research 33, 493-503.
29. Valdes, J., Taylor, M. C., Cross, M. A., Ligtenber, M. J. L., Rudenko, G., and Borst, P. 1996. The viral thymidine kinase gene as a tool for the study of mutagenesis in Trypanosoma brucei. Nucleic Acids Research 24, 1809-1815.
30. Van Voorhis, W. C., and Eisen, H. 1989. FL-160: A surface antigen of Trypanosoma cruzi that mimics mammalian nervous tissue. Journal of Experimental Medicine 169, 641-652.